Dr. Reeders is founder and Chief Executive Officer of MVM Limited. In this role, he has co-founded three biotechnology companies and currently serves as a Board Member of Nova Science Limited, Vasca Inc., and Oxxon Pharmaceuticals, Inc. Prior to founding MVM, Dr. Reeders led healthcare investing at Saunders, Karp & Megrue and served on the faculty at Yale University.
|